A quick sampling - UnitedHealthcare, which has ~16% total USA health insurance market share, has classed Sofdra as Tier 2 (higher price generic and lower price brand name drugs) under its large Medicaid plan as at 1 Aug 2024.
Promising considering this suggests it's seen as a preferred medication, and means significantly lower, and possibly no, co-pay and greater accessibility for users.
Note there are conditions as expected: PA (prior authorisation), QL (quantity limits) and AL (age limits).
Source, page 177: Michigan UnitedHealthcare Community Plan - Medicaid Preferred Drug List (PDL) - UnitedHealthcare Community Plan of Michigan (uhcprovider.com)
BOT - Anything but charting, page-10550
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
41.5¢ |
Change
-0.020(4.60%) |
Mkt cap ! $752.8M | |||
| Open | High | Low | Value | Volume |
| 44.0¢ | 44.5¢ | 41.5¢ | $3.653M | 8.543M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 158683 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 129823 | 1 |
View Market Depth
| Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |